Oculis Holding AG (OCS) Receivables - Other (2021 - 2025)

Oculis Holding AG's (OCS) quarterly Receivables - Other came in at $13.3 million in Q4 2025, up 305.86% year-on-year from $3.3 million in Q4 2024, and up 305.86% quarter-over-quarter from $3.3 million in Q4 2024.

Oculis Holding AG (OCS) Receivables - Other (2021 - 2025) Analysis & Trends

Oculis Holding AG's Receivables - Other history runs 5 years deep, the most recent figure standing at $13.3 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 305.86% year-over-year to $13.3 million in Q4 2025; TTM through Dec 2025 was $13.3 million, a 305.86% increase from a year earlier, with the FY2025 full-year figure at $12.9 million, up 292.91% from the prior year.
  • Receivables - Other rose to $13.3 million in Q4 2025 per OCS's latest filing, from $3.3 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $13.3 million in Q4 2025 and bottomed at $1038.0 in Q4 2022.
  • The 5-year median for Receivables - Other is $2.4 million (2023), against an average of $3.8 million.
  • Across the five-year window, Receivables - Other sank 96.7% in 2022 and surged 232859.95% in 2023, its largest moves.
  • Year by year, Receivables - Other stood at $31450.6 in 2021, then sank by 96.7% to $1038.0 in 2022, then jumped by 232859.95% to $2.4 million in 2023, then surged by 35.86% to $3.3 million in 2024, then surged by 305.86% to $13.3 million in 2025.
  • Per Business Quant, the three latest OCS Receivables - Other figures stand at $13.3 million (Q4 2025), $3.3 million (Q4 2024), and $2.4 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.33 Mn
Dec 31, 2025 13.33 Mn
Dec 31, 2024 3.29 Mn
Dec 31, 2024 3.29 Mn
Dec 31, 2023 2.42 Mn
Dec 31, 2023 2.42 Mn
Dec 31, 2022 1,038.02
Dec 31, 2022 1,038.02
Dec 31, 2021 31,450.56
Dec 31, 2021 31,450.56